about
Epidemiology of psychotropic drug use in Rio de Janeiro, Brazil: gaps in mental illness treatmentsPsychotropic Drug Use in São Paulo, Brazil--An Epidemiological SurveyBenzodiazepine Use, Misuse, and Harm at the Population Level in Canada: A Comprehensive Narrative Review of Data and Developments Since 1995.Effects of prescription adaptation by pharmacists.Descriptive epidemiology of major depressive disorder in Canada in 2012.The Falls/Fractures Economic Model in Ontario Residents Aged 65 Years and Over (FEMOR).Fitness to drive of psychiatric patients.Factors associated with antidepressant, anxiolytic, and other psychotropic medication use to treat psychiatric symptoms in the city of São Paulo, Brazil.The association of medications with sedative properties with oral health behaviour in community-dwelling older people.Sedative load, carious teeth and infection in the periodontium among community-dwelling older people.Use of psychotropic medications in São Paulo Metropolitan Area, Brazil: pattern of healthcare provision to general population.Childhood adversity and subsequent mental health status in adulthood: screening for associations using two linked surveys.A comparison of benzodiazepine and related drug use in Nova Scotia and Australia.[Factors associated with high exposure to psychotropic drugs in a Montreal catchment epidemiological area].Trends in psychotropic use in Saskatchewan from 1983 to 2007.Psychotropic medication claims among religious clergy.Prevalence and predictors of psychotropic medication use: results from the Northern Ireland Study of Health and Stress.Sedative load and salivary secretion and xerostomia in community-dwelling older people.Self-reported diagnoses of schizophrenia and psychotic disorders may be valuable for monitoring and surveillance.Antipsychotic Drug Dispensations in Older Adults, Including Continuation After a Fall-Related Hospitalization: Identifying Adherence to Screening Tool of Older Persons' Potentially Inappropriate Prescriptions Criteria Using the Nova Scotia Seniors' P
P2860
Q28487993-EC1C4BA3-9756-46FA-94C6-340609044359Q28547129-EC245667-0B8D-4F56-A10E-C7BB925D7CB2Q30251634-8044FBCC-3652-48F3-83C3-DB9C04050F0BQ33749038-22F14FF4-0652-496B-9110-1B5FCDE4E4CDQ35038748-A8E21539-EE7F-4B32-A29C-BEE5769239E9Q36040194-8F44FAC0-B968-4F91-9836-83582D4BF491Q37067975-108F2B77-BE3E-442C-BE8B-2EED11070171Q37672404-243B7936-D03F-45D4-8F36-0C3DAD2DE6B3Q38807335-F1E95101-D3D5-4028-B200-9EE580CD7BA8Q40269362-0B165BD9-D2A5-4FA7-B2B2-E825F7796BDAQ40758187-B3489630-BC08-4F3C-8F97-4875B10A34E6Q41356613-EDC0C36D-881A-4039-81FD-367966EAD13DQ43521322-78B3F7D8-AB8F-430F-82AA-39A045654699Q43550125-26A6F3DF-98C6-4B7B-99DB-CCB698DCF90CQ44842205-59CAB6C0-3AE1-4131-A098-370F8F11EAF4Q48436557-47AEE759-818E-4582-AE5B-0A4AF3F93B30Q50195340-FC46CAD6-D8B4-4D2C-863B-2DECC9FA90C7Q51840805-A32E7B35-A5B6-43EF-99F5-AB8832133ABCQ51918820-3EE5ABE8-E6D8-4F31-977F-94300226DBF1Q57192768-107A88AD-3891-4E03-827C-FC7B6B7F1CF7
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Psychotropic medication use in Canada.
@en
Psychotropic medication use in Canada.
@nl
type
label
Psychotropic medication use in Canada.
@en
Psychotropic medication use in Canada.
@nl
prefLabel
Psychotropic medication use in Canada.
@en
Psychotropic medication use in Canada.
@nl
P2093
P2860
P1476
Psychotropic medication use in Canada.
@en
P2093
Aliya Kassam
Colleen J Maxwell
Cynthia A Beck
Jeanne V A Williams
Jian Li Wang
Nady El-Guebaly
Scott B Patten
Shawn R Currie
P2860
P304
P356
10.1177/070674370505001006
P407
P577
2005-09-01T00:00:00Z